表紙
市場調查報告書
商品編碼
1066675

大腸癌症治療藥的全球市場(2022年∼2026年)

Global Colorectal Cancer Therapeutics Market 2022-2026

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球大腸癌症治療藥的市場規模在2022年∼2026年間,預測將成長到24億5,000萬美元,在預測期間內預計將以年複合成長率5.43%的成長。

市場成長的主要因素有老年人口的增加、結直腸癌發病率的增加以及聯合療法的引入。

本報告提供全球大腸癌症治療藥市場相關調查,提供市場概要,市場規模與預測,各地區形勢,促進因素,課題,企業分析等資訊。

目錄

第1章 摘要整理

第2章 市場形勢

  • 市場生態系統

第3章 市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模:2021年
  • 市場預測:2021年∼2026年的預測

第4章 波特的五力分析

  • 五力的摘要
  • 買方議價能力
  • 賣主談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

第5章 市場區隔:各類型

  • 市場區隔
  • 各類型的比較
  • 標靶治療:市場規模與預測
  • 免疫療法:市場規模與預測
  • 化療:市場規模與預測
  • 各類型的市場機會

第6章 客戶形勢

第7章 各地區形勢

  • 各地區市場區隔
  • 各地區的比較
  • 北美:市場規模與預測
  • 歐洲:市場規模與預測
  • 亞洲:市場規模與預測
  • 其他地區:市場規模與預測
  • 美國:市場規模與預測
  • 德國:市場規模與預測
  • 英國:市場規模與預測
  • 加拿大:市場規模與預測
  • 中國:市場規模與預測
  • 各地區形勢的市場機會

第8章 促進因素,課題,趨勢

  • 推動市場要素
  • 市場課題
  • 推動因素與課題的影響
  • 市場趨勢

第9章 業者情勢

  • 概要
  • 業者情勢
  • 混亂狀況
  • 產業的風險

第10章 供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Amgen Inc.
  • Bayer AG
  • Biocon Ltd.
  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Fresenius SE and Co. KGaA
  • Merck and Co. Inc.
  • Sanofi SA
  • Viatris Inc.

第11章 附錄

目錄
Product Code: IRTNTR72411

Technavio has been monitoring the colorectal cancer therapeutics market and it is poised to grow by $ 2.45 bn during 2022-2026 progressing at a CAGR of 5.43% during the forecast period. Our report on the colorectal cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing geriatric population, rising occurrence of colorectal cancer, and introduction of combination therapeutics.

The colorectal cancer therapeutics market analysis includes type segment and geographic landscape.

Technavio's colorectal cancer therapeutics market is segmented as below:

By Type

  • Targeted therapy
  • Immunotherapy
  • Chemotherapy

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the development of small molecule kinase inhibitors as one of the prime reasons driving the colorectal cancer therapeutics market growth during the next few years. Also, the advent of gene therapy and personalized therapeutics will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the colorectal cancer therapeutics market covers the following areas:

  • Colorectal cancer therapeutics market sizing
  • Colorectal cancer therapeutics market forecast
  • Colorectal cancer therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading colorectal cancer therapeutics market vendors that include Accord Healthcare Ltd., Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Biocon Ltd., Bristol-Myers Squibb Co., CK Hutchison Holdings Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE, and Co. KGaA, Hetero Drugs Ltd., Hikma Pharmaceuticals Plc, Merck and Co. Inc., Ono Pharmaceutical Co. Ltd., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. Also, the colorectal cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

  • 5.1 Market segments
  • Exhibit 24: Chart on Type - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
  • 5.2 Comparison by Type
  • Exhibit 26: Chart on Comparison by Type
  • Exhibit 27: Data Table on Comparison by Type
  • 5.3 Targeted therapy - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)
  • 5.4 Immunotherapy - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Immunotherapy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Immunotherapy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Immunotherapy - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Immunotherapy - Year-over-year growth 2021-2026 (%)
  • 5.5 Chemotherapy - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 37: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
  • 5.6 Market opportunity by Type
  • Exhibit 40: Market opportunity by Type ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 44: Chart on Geographic comparison
  • Exhibit 45: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Germany - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.9 UK - Market size and forecast 2021-2026
  • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.10 Canada - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.11 China - Market size and forecast 2021-2026
  • Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 85: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 86: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 87: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 88: Matrix on vendor position and classification
  • 10.3 Amgen Inc.
  • Exhibit 89: Amgen Inc. - Overview
  • Exhibit 90: Amgen Inc. - Business segments
  • Exhibit 91: Amgen Inc. - Key offerings
  • Exhibit 92: Amgen Inc. - Segment focus
  • 10.4 Bayer AG
  • Exhibit 93: Bayer AG - Overview
  • Exhibit 94: Bayer AG - Business segments
  • Exhibit 95: Bayer AG - Key news
  • Exhibit 96: Bayer AG - Key offerings
  • Exhibit 97: Bayer AG - Segment focus
  • 10.5 Biocon Ltd.
  • Exhibit 98: Biocon Ltd. - Overview
  • Exhibit 99: Biocon Ltd. - Business segments
  • Exhibit 100: Biocon Ltd. - Key offerings
  • Exhibit 101: Biocon Ltd. - Segment focus
  • 10.6 Bristol-Myers Squibb Co.
  • Exhibit 102: Bristol-Myers Squibb Co. - Overview
  • Exhibit 103: Bristol-Myers Squibb Co. - Product / Service
  • Exhibit 104: Bristol-Myers Squibb Co. - Key offerings
  • 10.7 Eli Lilly and Co.
  • Exhibit 105: Eli Lilly and Co. - Overview
  • Exhibit 106: Eli Lilly and Co. - Business segments
  • Exhibit 107: Eli Lilly and Co. - Key offerings
  • Exhibit 108: Eli Lilly and Co. - Segment focus
  • 10.8 F. Hoffmann La Roche Ltd.
  • Exhibit 109: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 110: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 111: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 112: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 113: F. Hoffmann La Roche Ltd. - Segment focus
  • 10.9 Fresenius SE and Co. KGaA
  • Exhibit 114: Fresenius SE and Co. KGaA - Overview
  • Exhibit 115: Fresenius SE and Co. KGaA - Business segments
  • Exhibit 116: Fresenius SE and Co. KGaA - Key offerings
  • Exhibit 117: Fresenius SE and Co. KGaA - Segment focus
  • 10.10 Merck and Co. Inc.
  • Exhibit 118: Merck and Co. Inc. - Overview
  • Exhibit 119: Merck and Co. Inc. - Business segments
  • Exhibit 120: Merck and Co. Inc. - Key news
  • Exhibit 121: Merck and Co. Inc. - Key offerings
  • Exhibit 122: Merck and Co. Inc. - Segment focus
  • 10.11 Sanofi SA
  • Exhibit 123: Sanofi SA - Overview
  • Exhibit 124: Sanofi SA - Business segments
  • Exhibit 125: Sanofi SA - Key news
  • Exhibit 126: Sanofi SA - Key offerings
  • Exhibit 127: Sanofi SA - Segment focus
  • 10.12 Viatris Inc.
  • Exhibit 128: Viatris Inc. - Overview
  • Exhibit 129: Viatris Inc. - Business segments
  • Exhibit 130: Viatris Inc. - Key offerings
  • Exhibit 131: Viatris Inc. - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 132: Inclusions checklist
  • Exhibit 133: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 134: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 135: Research methodology
  • Exhibit 136: Validation techniques employed for market sizing
  • Exhibit 137: Information sources
  • 11.5 List of abbreviations
  • Exhibit 138: List of abbreviations

Exhibits

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Type - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Type - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Type
  • Exhibits27: Data Table on Comparison by Type
  • Exhibits28: Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Immunotherapy - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Immunotherapy - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Immunotherapy - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Immunotherapy - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
  • Exhibits37: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
  • Exhibits38: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
  • Exhibits39: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
  • Exhibits40: Market opportunity by Type ($ million)
  • Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits44: Chart on Geographic comparison
  • Exhibits45: Data Table on Geographic comparison
  • Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits79: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits80: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Market opportunity By Geographical Landscape ($ million)
  • Exhibits83: Impact of drivers and challenges in 2021 and 2026
  • Exhibits84: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits85: Overview on factors of disruption
  • Exhibits86: Impact of key risks on business
  • Exhibits87: Vendors covered
  • Exhibits88: Matrix on vendor position and classification
  • Exhibits89: Amgen Inc. - Overview
  • Exhibits90: Amgen Inc. - Business segments
  • Exhibits91: Amgen Inc. - Key offerings
  • Exhibits92: Amgen Inc. - Segment focus
  • Exhibits93: Bayer AG - Overview
  • Exhibits94: Bayer AG - Business segments
  • Exhibits95: Bayer AG - Key news
  • Exhibits96: Bayer AG - Key offerings
  • Exhibits97: Bayer AG - Segment focus
  • Exhibits98: Biocon Ltd. - Overview
  • Exhibits99: Biocon Ltd. - Business segments
  • Exhibits100: Biocon Ltd. - Key offerings
  • Exhibits101: Biocon Ltd. - Segment focus
  • Exhibits102: Bristol-Myers Squibb Co. - Overview
  • Exhibits103: Bristol-Myers Squibb Co. - Product / Service
  • Exhibits104: Bristol-Myers Squibb Co. - Key offerings
  • Exhibits105: Eli Lilly and Co. - Overview
  • Exhibits106: Eli Lilly and Co. - Business segments
  • Exhibits107: Eli Lilly and Co. - Key offerings
  • Exhibits108: Eli Lilly and Co. - Segment focus
  • Exhibits109: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits110: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits111: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits112: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits113: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits114: Fresenius SE and Co. KGaA - Overview
  • Exhibits115: Fresenius SE and Co. KGaA - Business segments
  • Exhibits116: Fresenius SE and Co. KGaA - Key offerings
  • Exhibits117: Fresenius SE and Co. KGaA - Segment focus
  • Exhibits118: Merck and Co. Inc. - Overview
  • Exhibits119: Merck and Co. Inc. - Business segments
  • Exhibits120: Merck and Co. Inc. - Key news
  • Exhibits121: Merck and Co. Inc. - Key offerings
  • Exhibits122: Merck and Co. Inc. - Segment focus
  • Exhibits123: Sanofi SA - Overview
  • Exhibits124: Sanofi SA - Business segments
  • Exhibits125: Sanofi SA - Key news
  • Exhibits126: Sanofi SA - Key offerings
  • Exhibits127: Sanofi SA - Segment focus
  • Exhibits128: Viatris Inc. - Overview
  • Exhibits129: Viatris Inc. - Business segments
  • Exhibits130: Viatris Inc. - Key offerings
  • Exhibits131: Viatris Inc. - Segment focus
  • Exhibits132: Inclusions checklist
  • Exhibits133: Exclusions checklist
  • Exhibits134: Currency conversion rates for US$
  • Exhibits135: Research methodology
  • Exhibits136: Validation techniques employed for market sizing
  • Exhibits137: Information sources
  • Exhibits138: List of abbreviations